PMID- 22306699 OWN - NLM STAT- MEDLINE DCOM- 20120924 LR - 20220316 IS - 1873-3441 (Electronic) IS - 0939-6411 (Linking) VI - 81 IP - 1 DP - 2012 May TI - Efficacy of thiolated eudragit microspheres as an oral vaccine delivery system to induce mucosal immunity against enterotoxigenic Escherichia coli in mice. PG - 43-8 LID - 10.1016/j.ejpb.2012.01.010 [doi] AB - A vaccine delivery system based on thiolated eudragit microsphere (TEMS) was studied in vivo for its ability to elicit mucosal immunity against enterotoxigenic Escherichia coli (ETEC). Groups of mice were orally immunized with F4 or F18 fimbriae of ETEC and F4 or F18 loaded in TEMS. Mice that were orally administered with F4 or F18 loaded TEMS showed higher antigen-specific IgG antibody responses in serum and antigen-specific IgA in saliva and feces than mice that were immunized with antigens only. In addition, oral vaccination of F4 or F18 loaded TEMS resulted in higher numbers of IgG and IgA antigen-specific antibody secreting cells in the spleen, lamina propria, and Peyer's patches of immunized mice than other groups. Moreover, TEMS administration loaded with F4 or F18 induced mixed Th1 and Th2 type responses based on similarly increased levels of IgG1 and IgG2a. These results suggest that F4 or F18 loaded TEMS may be a promising candidate for an oral vaccine delivery system to elicit systemic and mucosal immunity against ETEC. CI - Copyright (c) 2012 Elsevier B.V. All rights reserved. FAU - Lee, Won-Jung AU - Lee WJ AD - Department of Infectious Diseases, College of Veterinary Medicine, KRF Zoonotic Disease Priority Research Institute, Seoul, Republic of Korea. FAU - Cha, Seungbin AU - Cha S FAU - Shin, Minkyoung AU - Shin M FAU - Jung, Myunghwan AU - Jung M FAU - Islam, Mohammad Ariful AU - Islam MA FAU - Cho, Chong-su AU - Cho CS FAU - Yoo, Han Sang AU - Yoo HS LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120128 PL - Netherlands TA - Eur J Pharm Biopharm JT - European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V JID - 9109778 RN - 0 (Antigens, Bacterial) RN - 0 (Escherichia coli Proteins) RN - 0 (FedA protein, E coli) RN - 0 (Immunoglobulin A) RN - 0 (Immunoglobulin G) RN - 0 (K88 antigen, E coli) RN - 0 (Polymethacrylic Acids) RN - 0 (Sulfhydryl Compounds) RN - 0 (Vaccines) RN - 147680-16-8 (Fimbriae Proteins) RN - 25086-15-1 (methylmethacrylate-methacrylic acid copolymer) SB - IM MH - Administration, Oral MH - Animals MH - Antigens, Bacterial/administration & dosage/immunology MH - Enterotoxigenic Escherichia coli/*immunology MH - Escherichia coli Infections/*immunology MH - Escherichia coli Proteins/administration & dosage/immunology MH - Female MH - Fimbriae Proteins/administration & dosage/immunology MH - Immunity, Mucosal MH - Immunoglobulin A/immunology MH - Immunoglobulin G/immunology MH - Mice MH - Mice, Inbred ICR MH - Microspheres MH - Polymethacrylic Acids/*chemistry MH - Sulfhydryl Compounds/chemistry MH - Vaccines/administration & dosage/*immunology EDAT- 2012/02/07 06:00 MHDA- 2012/09/25 06:00 CRDT- 2012/02/07 06:00 PHST- 2011/08/01 00:00 [received] PHST- 2011/12/30 00:00 [revised] PHST- 2012/01/18 00:00 [accepted] PHST- 2012/02/07 06:00 [entrez] PHST- 2012/02/07 06:00 [pubmed] PHST- 2012/09/25 06:00 [medline] AID - S0939-6411(12)00011-2 [pii] AID - 10.1016/j.ejpb.2012.01.010 [doi] PST - ppublish SO - Eur J Pharm Biopharm. 2012 May;81(1):43-8. doi: 10.1016/j.ejpb.2012.01.010. Epub 2012 Jan 28.